Bioavailability, Drug Delivery Systems, Drugs and FDA Approval

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioavailability

Drug Delivery Systems

Drugs

FDA Approval

Scilex buys rights to acute migraine treatment Elyxyb in Canada and the US

Pharmaceutical Technology

FEBRUARY 13, 2023

Elyxyb is a prescription nonsteroidal anti-inflammatory drug (NSAID) used for acute migraine treatment in adult patients with or without aura. It is formulated using a self-micro-emulsifying drug delivery system that improves the drug’s bioavailability and solubility.

Drug Delivery Systems

Drug Delivery Systems FDA Approval Bioavailability Drug Delivery

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

AUGUST 30, 2022

According to an analysis of the 2013 Medical Expenditure Panel Survey, one in six US adults reported taking a psychiatric drug at least once in 2013. Global sales of over-the-counter and prescription products related to central nervous system (CNS) disease added up to $86 billion in 2019.

Trials

Trials Drug Delivery Drugs Gene

Clinical Research Informer

Scilex buys rights to acute migraine treatment Elyxyb in Canada and the US

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

Stay Connected